d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A phase II open label, single arm study evaluating treatment with pazopanib post sunitinib treatment in patients with mRCC. [Country] SE [Cancer type] 
Urothelial
Nordic NECT - Inclusion completed
Cancer type